Core Viewpoint - Ultralife Corporation faced challenges in the second quarter of 2025, with flat organic sales in Battery & Energy Products and a significant decline in Communications Systems sales, but anticipates improved results in the second half of the year and into 2026 due to various factors including new product programs and increased demand from key sectors [1][2]. Financial Performance - Revenue for the second quarter was $48.6 million, a 13.0% increase from $43.0 million in the same quarter of 2024 [3][6]. - Battery & Energy Products sales rose by 25.0% to $45.9 million, largely due to the inclusion of Electrochem Solutions, Inc. [3][6]. - Excluding Electrochem, Battery & Energy Products sales were flat year-over-year, with government/defense sales up 61.1% but commercial sales down 20.4% [3][6]. - Communications Systems sales decreased by 57.2% to $2.7 million, primarily due to shipment delays and order timing issues [3][6]. Profitability Metrics - Gross profit was $11.6 million, representing 23.9% of revenue, down from 26.9% in the same quarter last year [4][6]. - Operating income was $2.3 million, a decline from $3.9 million in the prior year, with an operating margin of 4.6% compared to 9.1% [7][6]. - Net income attributable to Ultralife was $0.9 million, or $0.05 per diluted share, down from $3.0 million or $0.18 per diluted share in the second quarter of 2024 [9][6]. Operating Expenses - Operating expenses increased to $9.3 million from $7.6 million in the same quarter last year, reflecting higher costs associated with new product development and the inclusion of Electrochem [5][6]. - Operating expenses accounted for 19.2% of revenue, compared to 17.8% in the previous year [5][6]. Future Outlook - The company expects a rebound in its Communications Systems business and early purchase orders from new product programs in the battery segment, alongside growth in defense spending and opportunities in the oil & gas sector [2][1]. - Priorities include converting long-term product development into revenue and enhancing operational efficiency for sustainable growth [2][1].

Company Overview - Ultralife Corporation is set to report its second quarter results for the period ended June 30, 2025, before the market opens on August 7, 2025 [1] - The company will host an investor conference call and simultaneous webcast at Noon ET on the same day [1] Participation Details - Participants planning to join the conference call by phone must pre-register using a provided link to ensure a fast and reliable connection [2] - After registration, dial-in information and a personal identification number will be provided [2] Webcast Information - A live webcast of the conference call will be available in the Events & Presentations Section of the company's website [3] - A replay of the webcast will be accessible shortly after the call for those unable to listen live [3] Business Segments - Ultralife Corporation operates in two main business segments: Battery & Energy Products and Communications Systems [5] - The company serves government, defense, and commercial customers globally, with operations in North America, Europe, and Asia [4][5]

Financial Data and Key Metrics Changes - The company reported Q1 sales of $50.7 million, an increase from $41.9 million in the same quarter last year, representing a year-over-year growth of 21% [10] - Operating income for Q1 was $3.4 million, down from $4.1 million in the previous year, leading to a decrease in operating margin to 6.7% from 9.7% [15] - Net income was $1.9 million or $0.11 per share on a GAAP basis, compared to $2.9 million or $0.18 per share for the same quarter last year [15][16] - Adjusted EBITDA was $5.4 million, or 10.7% of sales, compared to $5.2 million or 12.5% for the prior year quarter [16] Business Line Data and Key Metrics Changes - Revenues from the Battery and Energy Products segment were $46.3 million, up from $35 million last year, with a 10.6% organic growth excluding Electrochem sales [10][11] - Government defense sales in the Battery segment increased by 53.6%, while medical battery sales decreased by 12.3% [11] - The Communications Systems segment saw revenues decline by 36.2% to $4.4 million, primarily due to large shipments in the prior year [12] Market Data and Key Metrics Changes - The sales split between commercial and government defense for the battery business was 64% to 36%, with a domestic to international sales split of 78% to 22% [11] - The total backlog exiting Q1 was $95 million, representing 55% of trailing twelve-month sales, indicating a healthy demand outlook [12] Company Strategy and Development Direction - The company is focused on completing the integration of the Electrochem acquisition, including ERP system setup, by the end of Q2 [18][26] - There is a commitment to improve sales pipelines and stabilize gross margins through pricing adjustments and lean productivity projects [19][20] - The company aims to leverage vertical integration opportunities from the Electrochem acquisition to enhance product offerings and market reach [18][37] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in profitable growth despite macroeconomic uncertainties, citing a strong backlog and expected recovery in medical sales in the latter half of the year [40][52] - The government defense sector is expected to remain robust, with potential increases in spending due to global conflicts and NATO commitments [52] - The company anticipates consistent free cash flow throughout 2025, with plans to pay down acquisition debt ahead of schedule [53][54] Other Important Information - The company is actively managing tariff impacts by passing along known costs as surcharges and exploring alternative supply sources [8][34] - The integration of Electrochem is expected to yield favorable contribution margins and enhance overall profitability [38] Q&A Session Summary Question: How have conversations with customers on tariff pass-throughs evolved? - Management noted that customers are concerned about cash flow impacts due to tariffs, which could affect their ability to invest in product development [32][33] Question: What are the major milestones left for the Electrochem integration? - The integration is on track, with most systems set up and the focus now on finalizing the ERP system [35][36] Question: What markets are targeted for the IVAS battery? - The primary focus is on foreign military markets, with some commercial engagements anticipated [39] Question: Can you discuss trends across key end markets? - The medical market is steady with known replacement cycles, while government defense remains strong with no expected downturn [50][52] Question: How do you expect free cash flow to trend over 2025? - Free cash flow is expected to be consistent, with a focus on maintaining a positive cash gap and paying down debt [53][54]

Financial Data and Key Metrics Changes - The company reported Q1 sales of $50.7 million, an increase from $41.9 million in the same quarter last year, representing a year-over-year growth of 21% [10] - Operating income for Q1 was $3.4 million, down from $4.1 million in the previous year, leading to a decrease in operating margin to 6.7% from 9.7% [15] - Net income was $1.9 million or $0.11 per share on a GAAP basis, compared to $2.9 million or $0.18 per share for the same quarter last year [15][16] - Adjusted EBITDA was $5.4 million, or 10.7% of sales, compared to $5.2 million or 12.5% for the prior year quarter [16] Business Line Data and Key Metrics Changes - Revenues from the Battery and Energy Products segment were $46.3 million, up from $35 million last year, with a 10.6% organic growth excluding Electrochem sales [10][11] - Government defense sales in the Battery segment increased by 53.6%, while medical battery sales decreased by 12.3% [11] - The Communications Systems segment saw revenues decline by 36.2% to $4.4 million, primarily due to large shipments in the prior year [12] Market Data and Key Metrics Changes - The sales split between commercial and government defense for the battery business was 64% to 36%, with a domestic to international split of 78% to 22% [11] - The total backlog exiting Q1 was $95 million, representing 55% of trailing twelve-month sales, indicating a healthy demand outlook [12] Company Strategy and Development Direction - The company is focused on completing the integration of the Electrochem acquisition, which is expected to enhance vertical integration opportunities and expand the addressable market [19][27] - There is a commitment to improve sales opportunity pipelines and stabilize gross margins through pricing adjustments and lean productivity projects [20][21] - The company is investing in new product development and marketing efforts to support targeted growth goals [9][20] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in profitable growth despite macroeconomic uncertainties, citing a strong backlog and expected recovery in medical sales in the latter half of the year [42][55] - The government defense business is expected to remain strong due to ongoing global conflicts and increased NATO spending [55] - The company anticipates continued cash flow consistency and plans to pay down acquisition debt ahead of schedule [56] Other Important Information - The company ended Q1 with working capital of $70 million and a current ratio of 3.2, indicating solid liquidity [17] - The company received $1.5 million from the employee retention credit, which was used to reduce acquisition debt [17] Q&A Session Summary Question: How have conversations with customers on tariff pass-throughs evolved? - Management noted that customers are concerned about cash flow impacts due to tariffs, which could affect their ability to invest in product development [33][34] Question: What are the major milestones left for the Electrochem integration? - The integration is on track, with most systems set up, and the focus is on completing the ERP system setup [36][37] Question: What markets are targeted for the IVAS battery? - The focus is primarily on foreign military markets, with some commercial engagements expected [41] Question: Can you discuss trends across key end markets? - The medical market is steady with known replacement cycles, while the government defense market remains strong with no expected fall-off in 2025 [53][55] Question: How do you expect free cash flow to trend over 2025? - Free cash flow is expected to be consistent, with plans to maintain a positive cash gap and continue paying down debt [56]

Financial Data and Key Metrics Changes - The company reported Q1 sales of $50.7 million, an increase from $41.9 million in the same quarter last year, representing a year-over-year growth of 21% [10][12] - Operating income for Q1 was $3.4 million, down from $4.1 million in the previous year, leading to a decrease in operating margin to 6.7% from 9.7% [15] - Net income was $1.9 million or $0.11 per share on a GAAP basis, compared to $2.9 million or $0.18 per share for the same quarter last year [15][16] - Adjusted EBITDA was $5.4 million, or 10.7% of sales, compared to $5.2 million or 12.5% for the prior year quarter [16] Business Line Data and Key Metrics Changes - Revenues from the Battery and Energy Products segment were $46.3 million, up from $35 million last year, with a 10.6% organic growth excluding Electrochem sales [10][11] - Government defense sales in the Battery segment increased by 53.6%, while medical battery sales decreased by 12.3% [11] - The Communications Systems segment saw revenues decline by 36.2% to $4.4 million, primarily due to large shipments in the prior year [12][14] Market Data and Key Metrics Changes - The sales split between commercial and government defense for the battery business was 64% to 36%, with a domestic to international split of 78% to 22% [11] - The total backlog exiting Q1 was $95 million, representing 55% of trailing twelve-month sales, indicating a healthy demand outlook [12] Company Strategy and Development Direction - The company aims to complete the integration of the Electrochem acquisition by the end of Q2, focusing on ERP system setup and leveraging vertical integration opportunities [19][27] - There is a commitment to improve sales pipelines and stabilize gross margins through pricing adjustments and lean productivity projects [20][21] - The company is expanding its product offerings in both the Communications Systems and Battery segments, targeting military and medical markets [22][24] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in profitable growth despite macroeconomic uncertainties, noting that Q1 performance exceeded expectations [42][43] - The government defense sector is expected to remain strong, with potential increases in NATO spending anticipated over the next 18 to 24 months [54] - The medical battery segment is expected to stabilize as replacement cycles for COVID-related devices approach [52] Other Important Information - The company ended Q1 with working capital of $70 million and a current ratio of 3.2, indicating solid liquidity [17] - The company received $1.5 million from the employee retention credit, which was used to reduce acquisition debt [17] Q&A Session Summary Question: How have conversations with customers on tariff pass-throughs evolved? - Management noted that customers are concerned about cash flow impacts due to tariffs, which could affect their ability to invest in product development [32][34] Question: What are the major milestones left for the Electrochem integration? - The integration is on track for completion by Q2, with most systems set up and data transitioned [36][37] Question: What markets are targeted for the IVAS battery? - The focus is primarily on foreign military markets, with some commercial engagements anticipated [41] Question: Can you discuss trends across key end markets? - The medical market is steady with known replacement cycles, while government defense remains strong with a good backlog [52][54] Question: How is free cash flow expected to trend over 2025? - Free cash flow is expected to be consistent, with plans to continue paying down debt ahead of schedule [55][56]

Core Insights - Ultralife Corporation reported a strong first quarter for 2025, with a 21% year-over-year revenue increase driven by robust growth in Battery & Energy Products, particularly in government/defense sales, and the contribution from the Electrochem acquisition [1][2] - The company is focused on improving gross margins and has successfully reduced inventory by 7%, which has freed up cash for strategic investments [1] - Ultralife is actively implementing a tariff mitigation plan to manage operational impacts from tariffs across its supply chains [1] Financial Performance - Revenue for the first quarter of 2025 was $50.7 million, an increase of $8.8 million or 21% compared to $41.9 million in the same quarter of 2024 [2][6] - Battery & Energy Products sales increased by 32.4% to $46.3 million, while Communications Systems sales decreased by 36.2% to $4.4 million [2][6] - Gross profit was $12.7 million, representing 25.1% of revenue, compared to $11.5 million or 27.4% of revenue in the prior year [3][6] Operating Metrics - Operating expenses rose to $9.3 million from $7.4 million in the previous year, reflecting the inclusion of Electrochem and increased costs for new product development [4][6] - Operating income decreased to $3.4 million, with an operating margin of 6.7%, down from 9.7% in the prior year [5][6] - Net income attributable to Ultralife Corporation was $1.9 million or $0.11 per diluted share, compared to $2.9 million or $0.18 per diluted share in the first quarter of 2024 [7][6] Backlog and Future Outlook - The total backlog and high-confidence orders at the end of the first quarter stood at $95.0 million, down from $102.2 million at the end of the fourth quarter of 2024, indicating a strong replenishment rate [2][6] - The company is confident in its ability to sustain profitable growth and generate incremental cash flow to reduce acquisition-related debt while continuing to invest in strategic product development [1]

Core Viewpoint - Ultralife Corporation is set to report its first quarter results for the period ending March 31, 2025, on May 9, 2025, before market opening [1] Group 1: Earnings Report - The earnings report will be followed by an investor conference call and webcast scheduled for 10:00 AM ET on the same day [1] - Participants are required to pre-register for the conference call to ensure a reliable connection [2] Group 2: Webcast Information - A live webcast of the conference call will be available on the company's website, with a replay accessible shortly after the call [3] Group 3: Company Overview - Ultralife Corporation provides a range of products and services, including power solutions and communications systems, serving government, defense, and commercial customers globally [4] - The company operates in two main segments: Battery & Energy Products and Communications Systems, with a presence in North America, Europe, and Asia [5]